Marine Derived Drugs Market Key Challenges and Growth Factors 2022 - 2028|Seattle Genetics, Eisai Co

 

Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.

The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Highlights
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Marine Derived Drugs market is projected to reach US$ 4257.5 million by 2028 from an estimated US$ 2566.7 million in 2022, at a CAGR of 8.8% during 2023 and 2028.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent

In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.

Get a PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, and Chart) :

https://www.qyresearch.com/sample-form/form/4986287/Global-Marine-Derived-Drugs-Market-Size-Manufacturers-Supply-Chain-Sales-Channel-and-Clients-2022-2028
 
Complete study of the global Marine Derived Drugs market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Marine Derived Drugs industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Marine Derived Drugs production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding of the overall existing and future market situation.

 
Segmental Analysis

The report has classified the global Marine Derived Drugs industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Marine Derived Drugs manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Marine Derived Drugs industry.

Global Marine Derived Drugs Market Segment By Type:

Mollusk
Sponge
Tunicate
Fish
Others

Global Marine Derived Drugs Market Segment By Application:

Antitumor Drugs
Anti-Cardiovascular Drugs
Others

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Marine Derived Drugs industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Marine Derived Drugs market include: Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva
 
Key questions answered in the report:

What is the growth potential of the Marine Derived Drugs market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Marine Derived Drugs industry in the years to come?
What are the key challenges that the global Marine Derived Drugs market may face in the future?
Which are the leading companies in the global Marine Derived Drugs market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain their hold in the global Marine Derived Drugs market?
 
Enquire Customization in The Report: 
 
https://www.qyresearch.com/customize-request/form/4986287/Global-Marine-Derived-Drugs-Market-Size-Manufacturers-Supply-Chain-Sales-Channel-and-Clients-2022-2028
 
 

Contact Us:
QY Research, INC.
17890 Castleton,
Suite 218,
City of Industry, CA - 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
 

This release was published on openPR.